Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia
Clinical trial NCT03188458 · TERMINATED
Trial details
- NCT number
- NCT03188458
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-29
- Primary completion
- 2018-10-22
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.